NCT07492095

Brief Summary

Leucine is an essential amino acid, which serves a special purpose of signaling cell growth in muscle in addition to making up protein. Essential amino acids like leucine need to be eaten every day from our foods like meat, dairy, eggs, beans, and nuts, as they cannot be made by our bodies. The current recommendation for leucine in the diet of school-age children are based upon adult needs. This study will measure the leucine requirement in children aged 6-10 years old using an non-invasive technique with special diets, safe stable isotopes, and simple breath collections. Creating guidelines based on measured requirements for leucine in this age group is essential for supporting optimal growth in healthy children.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for not_applicable

Timeline
18mo left

Started May 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
May 2026Dec 2027

First Submitted

Initial submission to the registry

March 19, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 25, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

March 25, 2026

Status Verified

March 1, 2026

Enrollment Period

11 months

First QC Date

March 19, 2026

Last Update Submit

March 19, 2026

Conditions

Keywords

LeucineSchool-Age ChildrenAmino AcidIsotope

Outcome Measures

Primary Outcomes (1)

  • Carbon-13 Oxidation

    9 breath samples will be collected during the study day, to measure the rate of oxidation of tracer phenylalanine in the expired breath.

    8 hours (1 study day)

Secondary Outcomes (1)

  • Urinary L-[1-13C] Phenylalanine Flux

    8 hours (1 study day)

Study Arms (1)

Test Leucine Intakes

EXPERIMENTAL

Randomized to receive 1 of 7 leucine intake levels (10, 20, 30, 40, 50, 60 or 80 mg/kg/d). Participants will complete up to 5 test intake allocations.

Dietary Supplement: Leucine Intake

Interventions

Leucine IntakeDIETARY_SUPPLEMENT

Participants consume 8 hourly meals that contain the assigned test leucine intake. Each meal will provide one-twelfth of the participants' daily energy requirements as estimated by 1.7 x Resting Energy Expenditure (REE) and adequate protein at 1.5 g/kg/d, to maintain a metabolic steady state. The meals are in the form of a crystalline amino acid protein shake, and protein-free cookies.

Test Leucine Intakes

Eligibility Criteria

Age6 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Healthy children
  • Aged 6 to 10 years at enrollment
  • Body weight between the 3rd and 85th percentile according to WHO Child Growth Standards
  • Assent from the child and written informed consent from parent(s) and/or legal guardian(s)

You may not qualify if:

  • Diagnosis of any acute or chronic medical condition
  • Current use of prescription medication that may affect protein or energy metabolism
  • Recent weight loss
  • Recent illness (fever, vomiting, severe runny nose within the past 5 days)
  • Inability to comply with study procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BC Children's Hospital Research Institute

Vancouver, British Columbia, V5Z 4H4, Canada

Location

Study Officials

  • Rajavel Elango

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 19, 2026

First Posted

March 25, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

March 25, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

There is no plan to share data with other researchers

Locations